Specialist Advice (Regulatory and Commercial) on the Development of TB Vaccines
What the buyer wrote
Bovine TB is one of GB's biggest endemic animal health issues, costing the taxpayer more than £100m a year. Over 28,000 cattle were slaughtered for TB control in England in 2015. Vaccination of either cattle or wildlife is an important long-term policy option for reducing the risk of bovine TB in England. As such, developing and licensing a cattle TB vaccine and an oral badger TB vaccine remains an important goal for the Department for Environment, Food, and Rural Affairs (Defra). MAFF/Defra have invested £35 million on cattle TB Vaccine and associated test development since it started this research programme in 1998. Since 2007 Defra has spent £23m on research and development (R&D) into ora…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Specialist Advice (Regulatory and Commercial) on the Development of TB Vaccines
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Work starts
- 17 Mar 2017
- Work ends
- 16 Mar 2018
- Kind of work
- Research, evaluation and insight, Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.